Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Short term Debt: 2014-2016

Historic Short term Debt for KalVista Pharmaceuticals (KALV) over the last 3 years, with Apr 2016 value amounting to $127,000.

  • KalVista Pharmaceuticals' Short term Debt rose 81.40% to $1.9 million in Q1 2016 from the same period last year, while for Mar 2016 it was $1.9 million, marking a year-over-year increase of 81.40%. This contributed to the annual value of $127,000 for FY2016, which is N/A change from last year.
  • According to the latest figures from FY2016, KalVista Pharmaceuticals' Short term Debt is $127,000, which was down 91.27% from $1.5 million recorded in FY2015.
  • Over the past 5 years, KalVista Pharmaceuticals' Short term Debt peaked at $4.4 million during FY2014, and registered a low of $127,000 during FY2016.
  • Over the past 3 years, KalVista Pharmaceuticals' median Short term Debt value was $1.5 million (recorded in 2015), while the average stood at $2.0 million.
  • Data for KalVista Pharmaceuticals' Short term Debt shows a maximum YoY tumbled of 67.19% (in 2015) over the last 5 years.
  • Over the past 3 years, KalVista Pharmaceuticals' Short term Debt (Yearly) stood at $4.4 million in 2014, then tumbled by 67.19% to $1.5 million in 2015, then reached $127,000 in 2016.